PPARG and gastric cancer: Moreover, Lu et al.[10] found that PPARγ (+/ − ) mice were more susceptible to MNU-induced gastriccancer than wild-type (+/+) mice, and troglitazone significantly reduced theincidence of gastric cancer in PPARγ (+/+) mice but not in PPARγ (+/ − ) mice.